Anzeige
Mehr »
Login
Sonntag, 22.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News: Vorweihnachtlicher Kaufrausch an der Börse?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JWL4 | ISIN: NO0010598683 | Ticker-Symbol: HBQ
Frankfurt
20.12.24
21:50 Uhr
0,132 Euro
-0,001
-0,75 %
1-Jahres-Chart
HOFSETH BIOCARE ASA Chart 1 Jahr
5-Tage-Chart
HOFSETH BIOCARE ASA 5-Tage-Chart
RealtimeGeldBriefZeit
0,1320,18021.12.

Aktuelle News zur HOFSETH BIOCARE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
HOFSETH BIOCARE Aktie jetzt für 0€ handeln
12.12.Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION3
09.12.Hofseth BioCare building second hydrolysis plant to extract nutrients from Atlantic salmon1
05.12.Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity55Hofseth BioCare ASA ("HBC" or the "Company", and together with its consolidated subsidiaries, the "Group") is pleased to announce a Board resolution to start a project to build a second hydrolysis...
► Artikel lesen
08.11.Hofseth BioCare ASA: Financial calendar-
08.11.Hofseth Biocare ASA: Third Quarter 2024 Financial Report86HBC had gross operating revenues of NOK 67.9m (49.9m) in the third quarter and NOK 200.6m (171.1m) in the first nine months. The operating loss (EBITDA) for the quarter was NOK -21.0m (-16.2m) and NOK...
► Artikel lesen
22.10.Hofseth Biocare ASA: CFO RESIGNATION5
08.10.Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT2
23.08.Hofseth Biocare ASA: Second Quarter And Half Year 2024 Financial Report102HBC had gross operating revenues of NOK 80.4m (76.4m) in the second quarter and NOK 132.8m (121.2m) for the half year. Adjusted for the sale of assets in the second quarter, sales revenues were NOK...
► Artikel lesen
14.08.Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE'S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY2
02.07.Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.134Ålesund, 02.07.24, Hofseth BioCare ASA ("HBC" or the "Company"), a global leader in marine lipid and peptide research, today announces the decision to transfer its eosinophil-targeting drug candidate...
► Artikel lesen
16.05.Hofseth Biocare ASA: First Quarter 2024 Financial Report195The first quarter of 2024 continued on the positive trend for HBC. Sales revenues came in at NOK 52m vs NOK 44m last year, a growth of 17 % YoY. The underlying growth we are seeing is coming from both...
► Artikel lesen
09.02.Hofseth Biocare ASA: Fourth Quarter 2023 And Full Year Financial Report332HBC had gross operating revenues of NOK 47.4m (33.6m) in the fourth quarter and NOK 218.5m (120.4m) for the full year. Adjusted for the sale of assets in the second quarter, operating revenues were...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1